3Moretti EW, Robertson KM, EI-Moalem H, et al. Intraoperative colloid administration reduces postoperative nausea and vomiting and improves postoperative outcomes compared with crystalloid administration. Anesth Analg, 2003,96 : 611-617.
4Friedman Z, Berkenstadt H, Preisman S, et al. A comparison of lactated ringer's solution to hydroxyethyl starch 6% in a model of severe hemorrhagic shock and continuous bleeding in dogs. Anesth Analg, 2003,96 : 39-45.
3Rimola A, Gavaler JS,Schade RR, et al, Effects of renal impairmerit on Liver transplantation. Gastroenterol, 1987,93:148-156.
4Burchardi H,Kaczmarczyk G. The effect of anesthesia on renal function. Eur J Anesthesiol, 1994,11 : 163-168.
5Wu YM, Yoigt M, Rayhill S, et al. Suprahepatic venacaplasty (cavaplasty) with retrohepatic cava extension in liver transplantation: experience with first 115 cases [ J ]. Transplantation, 2001,72(8) : 1389 -1394.
6Eyraud D, Richard O, Borie DC, et al. Hemodynamic and hormonal responses to the sudden interruption of caval flow: insights from a prospective study of hepatic vascular exclusion during major liver resections [ J ]. Anesth Analg, 2000, 95 ( 5 ) : 1173 - 1178.
8Luc M, Serge L, Lynda T, et al. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantation [ J ]. Liver Transplantation, 2006,12(1) :117 -123.
1Kozaki K,Egawa H, Kasahara M, et al. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation. Ther Apher Dial, 2005,9 (4):285-291.
2Takahashi K,Saito K, Takahara S, et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplanta tion in Japan. AM J Tansplant,2004,4(7):1089-1096.
3Sanchez-Urdazpal L, Batts KP, Gores GJ, et al. Increased bile duct complications in liver transplantation across the ABO barrier. Ann Surg, 1993,218(2): 152-158.
